Exicure, Inc. (XCUR)
1.12
-0.09
(-7.44%)
USD |
NASDAQ |
Oct 15, 16:00
1.12
0.00 (0.00%)
After-Hours: 20:00
Exicure Cash from Operations (TTM) : -6.704M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.704M |
| March 31, 2026 | -8.099M |
| December 31, 2025 | -8.555M |
| September 30, 2025 | -8.253M |
| June 30, 2025 | -5.174M |
| March 31, 2025 | -4.058M |
| December 31, 2024 | -2.91M |
| September 30, 2024 | -2.881M |
| June 30, 2024 | -3.844M |
| March 31, 2024 | -7.489M |
| December 31, 2023 | -10.36M |
| September 30, 2023 | -16.82M |
| June 30, 2023 | -21.95M |
| March 31, 2023 | -26.22M |
| December 31, 2022 | -36.16M |
| September 30, 2022 | -42.68M |
| Date | Value |
|---|---|
| June 30, 2022 | -31.27M |
| March 31, 2022 | -33.27M |
| December 31, 2021 | -34.82M |
| September 30, 2021 | -32.83M |
| June 30, 2021 | -46.24M |
| March 31, 2021 | -46.23M |
| December 31, 2020 | -39.27M |
| September 30, 2020 | -12.13M |
| June 30, 2020 | -8.549M |
| March 31, 2020 | -2.518M |
| December 31, 2019 | 1.317M |
| September 30, 2019 | -19.98M |
| June 30, 2019 | -19.20M |
| March 31, 2019 | -18.85M |
| December 31, 2018 | -19.49M |
| September 30, 2018 | -18.87M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Tenax Therapeutics, Inc. | -46.03M |
| Century Therapeutics, Inc. | -86.74M |
| Absci Corp. | -108.08M |
| Celularity, Inc. | -8.814M |
| Cardio Diagnostics Holdings, Inc. | -5.660M |